Literature DB >> 15322054

Protection of black-tailed prairie dogs (Cynomys ludovicianus) against plague after voluntary consumption of baits containing recombinant raccoon poxvirus vaccine.

Jordan S Mencher1, Susan R Smith, Tim D Powell, Dan T Stinchcomb, Jorge E Osorio, Tonie E Rocke.   

Abstract

Prairie dogs (Cynomys spp.) are highly susceptible to Yersinia pestis and significant reservoirs of plague for humans in the western United States. A recombinant raccoon poxvirus, expressing the F1 antigen of Y. pestis, was incorporated into a palatable bait and offered to 18 black-tailed prairie dogs (Cynomys ludovicianus) for voluntary consumption; 18 negative control animals received placebo baits. Antibody titers against Y. pestis F1 antigen increased significantly (P < 0.01) in vaccinees, and their survival was significantly higher upon challenge with Y. pestis than that of negative controls (P < 0.01).

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15322054      PMCID: PMC517477          DOI: 10.1128/IAI.72.9.5502-5505.2004

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  12 in total

1.  Sylvatic plague studies: The vector efficiency of nine species of fleas compared with Xenopsylla cheopis.

Authors:  A L Burroughs
Journal:  J Hyg (Lond)       Date:  1947-08

Review 2.  Yersinia pestis--etiologic agent of plague.

Authors:  R D Perry; J D Fetherston
Journal:  Clin Microbiol Rev       Date:  1997-01       Impact factor: 26.132

3.  Plague in a complex of white-tailed prairie dogs and associated small mammals in Wyoming.

Authors:  S H Anderson; E S Williams
Journal:  J Wildl Dis       Date:  1997-10       Impact factor: 1.535

4.  Dynamics of plague in a Gunnison's prairie dog colony complex from New Mexico.

Authors:  J F Cully; A M Barnes; T J Quan; G Maupin
Journal:  J Wildl Dis       Date:  1997-10       Impact factor: 1.535

5.  Prevention of the spread of rabies to wildlife by oral vaccination of raccoons in Massachusetts.

Authors:  A H Robbins; M D Borden; B S Windmiller; M Niezgoda; L C Marcus; S M O'Brien; S M Kreindel; M W McGuill; A DeMaria; C E Rupprecht; S Rowell
Journal:  J Am Vet Med Assoc       Date:  1998-11-15       Impact factor: 1.936

6.  Protection against experimental bubonic and pneumonic plague by a recombinant capsular F1-V antigen fusion protein vaccine.

Authors:  D G Heath; G W Anderson; J M Mauro; S L Welkos; G P Andrews; J Adamovicz; A M Friedlander
Journal:  Vaccine       Date:  1998-07       Impact factor: 3.641

7.  Raccoon poxvirus as a mucosal vaccine vector for domestic cats.

Authors:  Jorge E Osorio; Rexann S Frank; Kelley Moss; Terri Taraska; Tim Powell; Dan T Stinchcomb
Journal:  J Drug Target       Date:  2003       Impact factor: 5.121

8.  Recombinant raccoon pox vaccine protects mice against lethal plague.

Authors:  Jorge E Osorio; Tim D Powell; Rexann S Frank; Kelley Moss; Elizabeth J Haanes; Susan R Smith; Tonie E Rocke; Dan T Stinchcomb
Journal:  Vaccine       Date:  2003-03-07       Impact factor: 3.641

9.  Successful oral rabies vaccination of raccoons with raccoon poxvirus recombinants expressing rabies virus glycoprotein.

Authors:  J J Esposito; J C Knight; J H Shaddock; F J Novembre; G M Baer
Journal:  Virology       Date:  1988-07       Impact factor: 3.616

10.  Raccoon poxvirus feline panleukopenia virus VP2 recombinant protects cats against FPV challenge.

Authors:  L Hu; J J Esposito; F W Scott
Journal:  Virology       Date:  1996-04-01       Impact factor: 3.616

View more
  23 in total

Review 1.  Developing live vaccines against plague.

Authors:  Wei Sun; Kenneth L Roland; Roy Curtiss
Journal:  J Infect Dev Ctries       Date:  2011-09-14       Impact factor: 0.968

2.  Resistance to plague among black-tailed prairie dog populations.

Authors:  Tonie E Rocke; Judy Williamson; Kacy R Cobble; Joseph D Busch; Michael F Antolin; David M Wagner
Journal:  Vector Borne Zoonotic Dis       Date:  2011-09-16       Impact factor: 2.133

3.  Classic flea-borne transmission does not drive plague epizootics in prairie dogs.

Authors:  Colleen T Webb; Christopher P Brooks; Kenneth L Gage; Michael F Antolin
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-07       Impact factor: 11.205

Review 4.  Plague Vaccines: Status and Future.

Authors:  Wei Sun
Journal:  Adv Exp Med Biol       Date:  2016       Impact factor: 2.622

5.  Efficacy and safety of a modified vaccinia Ankara (MVA) vectored plague vaccine in mice.

Authors:  Joseph N Brewoo; Tim D Powell; Dan T Stinchcomb; Jorge E Osorio
Journal:  Vaccine       Date:  2010-07-12       Impact factor: 3.641

6.  Behavioral intoxication following voluntary oral ingestion of tetramethylenedisulfotetramine: Dose-dependent onset, severity, survival, and recovery.

Authors:  Nathaniel C Rice; Noah A Rauscher; Jeffrey L Langston; Todd M Myers
Journal:  Neurotoxicology       Date:  2017-09-07       Impact factor: 4.294

7.  Oral vaccination reduces the incidence of tuberculosis in free-living brushtail possums.

Authors:  D M Tompkins; D S L Ramsey; M L Cross; F E Aldwell; G W de Lisle; B M Buddle
Journal:  Proc Biol Sci       Date:  2009-06-03       Impact factor: 5.349

8.  Behavioral toxicity of sodium cyanide following oral ingestion in rats: Dose-dependent onset, severity, survival, and recovery.

Authors:  Nathaniel C Rice; Noah A Rauscher; Jeffrey L Langston; Todd M Myers
Journal:  Food Chem Toxicol       Date:  2018-02-16       Impact factor: 6.023

9.  Potent oncolytic activity of raccoonpox virus in the absence of natural pathogenicity.

Authors:  Laura Evgin; Markus Vähä-Koskela; Julia Rintoul; Theresa Falls; Fabrice Le Boeuf; John W Barrett; John C Bell; Marianne M Stanford
Journal:  Mol Ther       Date:  2010-02-16       Impact factor: 11.454

10.  Age at Vaccination May Influence Response to Sylvatic Plague Vaccine (SPV) in Gunnison's Prairie Dogs (Cynomys gunnisoni).

Authors:  Tonie E Rocke; Dan Tripp; Faye Lorenzsonn; Elizabeth Falendysz; Susan Smith; Judy Williamson; Rachel Abbott
Journal:  Ecohealth       Date:  2015-01-15       Impact factor: 4.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.